Delaware Clinical and Translational Research ACCEL Program (Admin Core)

特拉华州临床和转化研究 ACCEL 计划(管理核心)

基本信息

  • 批准号:
    10892513
  • 负责人:
  • 金额:
    $ 30.16万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-09-25 至 2028-06-30
  • 项目状态:
    未结题

项目摘要

ABSTRACT- ADMINISTRATIVE CORE The ACCEL CTR Program has successfully met the expectations of this award mechanism by expanding the capacity for clinical and translational research in Delaware and enhancing our investigators’ ability to successfully compete for extramural funding in this arena. The success of ACCEL is anchored in the complementary strengths of the partnership network been built over the past nine years. Our current network consists of the University of Delaware (lead institution), Christiana Care Health System, Nemours Children’s Health and Delaware State University—an American, historically Black, public university. To date, ACCEL has established an exceedingly strong network and infrastructure for clinical and translational research within Delaware; and, we are now poised and ready to continue our growth trajectory by building a deeper focus on health equity into our clinical and translational research infrastructure. The planned components of the ACCEL Program include the Administrative Core and five other required Cores, including: the Professional Development Core; the Biostatistics, Epidemiology, & Research Design Core; the Community Engagement & Outreach Core; the Pilot Projects Program, and the Tracking and Evaluation Core. The overall goal of the Administrative Core is to improve the efficiency, productivity and impact of the five other Cores so that we are able to successfully meet our common mission of building clinical and translational research infrastructure that will be sustainable and ultimately improve the health of Delawareans. We believe that we have a very effective administrative structure that does not require substantial change. But, in this renewal application, we propose an exciting new addition to the Administrative Core—a Health Equity Navigator, who will work closely with all Core leaders to weave the thread of health equity throughout all aspects of the ACCEL program. The Health Equity Navigator will keep the network focused on health equity as we strengthen our clinical and translational research infrastructure. The Specific Aims of the Administrative Core are to continue to: (1) Provide a flexible and efficient administrative and governance structure that enhances the DE-CTR ACCEL Program’s ability to grow and sustain clinical and translational research programs that address the most important health care needs of Delawareans and all Americans; (2) Manage the financial and business operations of the DE-CTR ACCEL Program to ensure operational efficiency, sound fiscal health of the organization and compliance with all federal, state and local regulations; (3) Enhance and promote data-informed decision-making, communication and collaboration across all ACCEL components, participating institutions and other IDeA programs; and (4) Facilitate the implementation of strategic, high- value initiatives that will enhance the ACCEL Program’s ability to address health inequities and improve infrastructure for clinical and translational research within the state of Delaware.
摘要-行政核心 ACCEL CTR 计划成功地满足了这一奖励机制的期望,通过扩大 特拉华州的临床和转化研究能力,并提高我们的研究人员的能力 ACCEL 的成功在于: 我们目前的合作伙伴网络是在过去九年中建立起来的优势互补的。 网络由特拉华大学(牵头机构)、克里斯蒂安娜护理卫生系统、 内穆尔儿童健康中心和特拉华州立大学——美国历史上黑人公立大学 迄今为止,ACCEL 已建立了极其强大的临床网络和基础设施。 以及特拉华州的转化研究;并且,我们现在已准备好继续发展。 通过在我们的临床和转化研究中更深入地关注健康公平来实现这一目标 ACCEL 计划的计划组成部分包括行政核心和五个基础设施。 其他所需的核心,包括:专业发展核心;生物统计学、流行病学和 研究设计核心;社区参与和外展核心;以及 跟踪和评估核心 行政核心的总体目标是改进 其他五个核心的效率、生产力和影响力,使我们能够成功地满足我们的目标 建立可持续且可持续的临床和转化研究基础设施的共同使命 我们相信我们拥有非常有效的行政管理,最终改善特拉华州人民的健康。 不需要进行实质性改变的结构但是,在这个更新申请中,我们提出了一个。 行政核心新增令人兴奋的成员——健康公平导航员,他将与所有人密切合作 核心领导者将健康公平的主线贯穿于 ACCEL 计划的各个方面。 随着我们加强临床和治疗,健康公平导航器将保持网络专注于健康公平 转化研究基础设施。行政核心的具体目标是继续:(1) 提供灵活高效的行政和治理结构,增强 DE-CTR ACCEL 计划发展和维持临床和转化研究项目的能力,这些项目解决 (二)财务管理 DE-CTR ACCEL 计划的业务运营,以确保运营效率和良好的财务状况 (三)加强和促进 所有 ACCEL 组件之间基于数据的决策、沟通和协作, 参与机构和其他 IDeA 计划;以及 (4) 促进战略性、高水平的实施 重视将增强 ACCEL 计划解决健康不平等问题和改善健康状况的能力的举措 特拉华州临床和转化研究基础设施。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Gregory E Hicks其他文献

Gregory E Hicks的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Gregory E Hicks', 18)}}的其他基金

Turning the TiDe: Training Diverse Clinician Scientists in Rehabilitation Research
扭转局势:培训康复研究领域的多元化临床科学家
  • 批准号:
    10686197
  • 财政年份:
    2022
  • 资助金额:
    $ 30.16万
  • 项目类别:
Delaware Clinical and Translational Research ACCEL Program
特拉华州临床和转化研究 ACCEL 计划
  • 批准号:
    10437677
  • 财政年份:
    2013
  • 资助金额:
    $ 30.16万
  • 项目类别:
Delaware Clinical and Translational Research ACCEL Program
特拉华州临床和转化研究 ACCEL 计划
  • 批准号:
    10885455
  • 财政年份:
    2013
  • 资助金额:
    $ 30.16万
  • 项目类别:
Delaware Clinical and Translational Research ACCEL Program
特拉华州临床和转化研究 ACCEL 计划
  • 批准号:
    10841849
  • 财政年份:
    2013
  • 资助金额:
    $ 30.16万
  • 项目类别:
Delaware Clinical and Translational Research ACCEL Program
特拉华州临床和转化研究 ACCEL 计划
  • 批准号:
    10721011
  • 财政年份:
    2013
  • 资助金额:
    $ 30.16万
  • 项目类别:
Delaware Clinical and Translational Research ACCEL Program-Admin Core
特拉华州临床和转化研究 ACCEL 计划-管理核心
  • 批准号:
    10437678
  • 财政年份:
    2013
  • 资助金额:
    $ 30.16万
  • 项目类别:
Delaware Clinical and Translational Research ACCEL Program
特拉华州临床和转化研究 ACCEL 计划
  • 批准号:
    10372245
  • 财政年份:
    2013
  • 资助金额:
    $ 30.16万
  • 项目类别:
Resveratrol for the prevention of bone loss in postmenopausal women with osteopenia
白藜芦醇预防绝经后骨质减少女性骨质流失
  • 批准号:
    10728055
  • 财政年份:
    2013
  • 资助金额:
    $ 30.16万
  • 项目类别:
Delaware Clinical and Translational Research ACCEL Program (Admin Core)
特拉华州临床和转化研究 ACCEL 计划(管理核心)
  • 批准号:
    10721012
  • 财政年份:
    2013
  • 资助金额:
    $ 30.16万
  • 项目类别:
Delaware Clinical and Translational Research ACCEL Program
特拉华州临床和转化研究 ACCEL 计划
  • 批准号:
    10223322
  • 财政年份:
    2013
  • 资助金额:
    $ 30.16万
  • 项目类别:

相似海外基金

Philadelphia Regional Center for Children’s Environmental Health
费城儿童环境健康区域中心
  • 批准号:
    10534772
  • 财政年份:
    2021
  • 资助金额:
    $ 30.16万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10655423
  • 财政年份:
    2020
  • 资助金额:
    $ 30.16万
  • 项目类别:
Utah Center for Clinical and Translational Science
犹他州临床和转化科学中心
  • 批准号:
    10162753
  • 财政年份:
    2018
  • 资助金额:
    $ 30.16万
  • 项目类别:
Utah Center for Clinical and Translational Science
犹他州临床和转化科学中心
  • 批准号:
    10363309
  • 财政年份:
    2018
  • 资助金额:
    $ 30.16万
  • 项目类别:
Utah Center for Clinical and Translational Science
犹他州临床和转化科学中心
  • 批准号:
    10361302
  • 财政年份:
    2018
  • 资助金额:
    $ 30.16万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了